Ensysce Biosciences Inc (ENSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -179 | -1,730 | 1,793 | -1,067 | 1,685 |
| Depreciation Amortization | 0 | 0 | 31 | N/A | N/A |
| Income taxes - deferred | N/A | N/A | N/A | -2 | 7 |
| Other Working Capital | -314 | -514 | 755 | 2,461 | 849 |
| Other Operating Activity | -221 | 1,683 | -2,814 | -2,817 | -3,540 |
| Operating Cash Flow | $-714 | $-561 | $-234 | $-1,425 | $-999 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | N/A | N/A | -1,699 | -566 | N/A |
| Other Investing Activity | 0 | 0 | 136,324 | 12,420 | 623 |
| Investing Cash Flow | $-4 | $N/A | $134,625 | $11,853 | $623 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,100 | 800 | 1,000 | 566 | N/A |
| Common Stock Repurchased | N/A | N/A | -136,284 | -11,584 | N/A |
| Other Financing Activity | 0 | 0 | 0 | -9 | -9 |
| Financing Cash Flow | $1,100 | $800 | $-135,284 | $-11,026 | $-9 |
| Beginning Cash Position | 342 | 342 | 1,061 | 1,658 | 1,658 |
| End Cash Position | 724 | 581 | 168 | 1,061 | 1,274 |
| Net Cash Flow | $383 | $239 | $-893 | $-597 | $-385 |
| Free Cash Flow | |||||
| Operating Cash Flow | -714 | -561 | -234 | -1,425 | -999 |
| Capital Expenditure | -4 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -717 | -561 | -234 | -1,425 | -999 |